|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 07/05/15 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 29/04/15 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +4.16% | +3.42% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.31B | |
| +2.76% | -1.60% | -3.98% | +2.68% | +16.46% | +22.80% | +78.53% | +228.53% | +5,432.14% | 56.95B | |
| +0.24% | -1.34% | +2.78% | -0.72% | +7.14% | +3.41% | +34.31% | -17.64% | +209.45% | 48.3B | |
| -3.91% | -2.06% | -3.41% | +5.41% | +151.42% | +329.93% | +699.76% | +623.74% | - | 44.51B | |
| -0.79% | -1.76% | +1.95% | +28.30% | +17.23% | +28.89% | +33.03% | +10.38% | +233.36% | 43.8B | |
| +1.09% | +0.10% | +4.02% | +18.15% | +20.34% | +6.12% | +110.27% | +7.85% | +1,050.11% | 41.12B | |
| -0.11% | +2.30% | -3.03% | -0.65% | +5.81% | +9.19% | +58.68% | +1.77% | +144.64% | 31.07B | |
| +4.51% | +8.43% | +17.73% | +54.15% | +84.16% | +37.27% | +34.97% | -50.85% | - | 28.97B | |
| -1.11% | -0.76% | -0.85% | +4.15% | +2.76% | -6.98% | -12.04% | -58.57% | - | 24.53B | |
| +1.40% | -8.86% | -15.62% | -5.52% | -39.45% | -33.42% | +331.18% | +283.76% | +624.26% | 22.67B | |
| +4.42% | +7.12% | +15.93% | +35.81% | +22.45% | +17.13% | -0.28% | -10.88% | +118.49% | 21.31B | |
| -1.47% | -1.69% | +3.50% | +8.23% | +8.89% | +15.33% | +148.53% | +217.70% | +1,980.91% | 17.32B | |
| -1.26% | +1.73% | -10.31% | -6.57% | +177.32% | +133.17% | +345.74% | +1,714.84% | +655.31% | 15.53B | |
| +0.63% | +0.76% | -14.91% | -14.22% | - | - | - | - | - | 14.98B | |
| +0.79% | -0.08% | +6.34% | +10.83% | +22.02% | +22.53% | +43.82% | -29.15% | +85.21% | 14.7B | |
| -0.99% | -0.51% | +1.18% | +5.08% | +33.13% | +45.84% | +162.60% | +179.19% | +342.72% | 14.58B | |
| +1.75% | +5.01% | -2.33% | -4.21% | +21.88% | -14.87% | +512.82% | - | - | 14.31B | |
| -0.49% | +4.42% | +10.07% | +33.53% | +54.92% | +76.64% | +59.74% | -24.22% | +270.98% | 14.84B | |
| -10.81% | -9.68% | +16.02% | +22.88% | +26.32% | -19.86% | - | - | - | 15.08B | |
| Average | +0.05% | -0.53% | +1.78% | +12.22% | +39.86% | +40.14% | +160.93% | +192.87% | +928.97% | 27.94B | |
| Weighted average by Cap. | +0.65% | -0.70% | +2.13% | +14.43% | +43.04% | +47.98% | +150.30% | +149.64% | +1,311.56% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
